Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.
Preston, Roger J S
Ainle, Fionnuala Ni
Johnson, Jennifer A
Cunningham, Moya S
Smith, Owen P
O'Donnell, James S
AffiliationHaemostasis Research Group, Institute of Molecular Medicine, St James's Hospital, Trinity College, Dublin 8, Ireland.
MeSHAmino Acid Substitution
Receptors, Cell Surface
MetadataShow full item record
CitationDissociation of activated protein C functions by elimination of protein S cofactor enhancement. 2008, 283 (45):30531-9 J. Biol. Chem.
JournalThe Journal of biological chemistry
AbstractActivated protein C (APC) plays a critical anticoagulant role in vivo by inactivating procoagulant factor Va and factor VIIIa and thus down-regulating thrombin generation. In addition, APC bound to the endothelial cell protein C receptor can initiate protease-activated receptor-1 (PAR-1)-mediated cytoprotective signaling. Protein S constitutes a critical cofactor for the anticoagulant function of APC but is not known to be involved in regulating APC-mediated protective PAR-1 signaling. In this study we utilized a site-directed mutagenesis strategy to characterize a putative protein S binding region within the APC Gla domain. Three single amino acid substitutions within the APC Gla domain (D35T, D36A, and A39V) were found to mildly impair protein S-dependent anticoagulant activity (<2-fold) but retained entirely normal cytoprotective activity. However, a single amino acid substitution (L38D) ablated the ability of protein S to function as a cofactor for this APC variant. Consequently, in assays of protein S-dependent factor Va proteolysis using purified proteins or in the plasma milieu, APC-L38D variant exhibited minimal residual anticoagulant activity compared with wild type APC. Despite the location of Leu-38 in the Gla domain, APC-L38D interacted normally with endothelial cell protein C receptor and retained its ability to trigger PAR-1 mediated cytoprotective signaling in a manner indistinguishable from that of wild type APC. Consequently, elimination of protein S cofactor enhancement of APC anticoagulant function represents a novel and effective strategy by which to separate the anticoagulant and cytoprotective functions of APC for potential therapeutic gain.
- Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.
- Authors: Yang L, Bae JS, Manithody C, Rezaie AR
- Issue date: 2007 Aug 31
- Multifunctional specificity of the protein C/activated protein C Gla domain.
- Authors: Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlbäck B, Lane DA
- Issue date: 2006 Sep 29
- Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.
- Authors: Ní Ainle F, O'Donnell JS, Johnson JA, Brown L, Gleeson EM, Smith OP, Preston RJ
- Issue date: 2011 Jan 14
- Platelet factor 4 impairs the anticoagulant activity of activated protein C.
- Authors: Preston RJ, Tran S, Johnson JA, Ní Áinle F, Harmon S, White B, Smith OP, Jenkins PV, Dahlbäck B, O'Donnell JS
- Issue date: 2009 Feb 27
- Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
- Authors: Mosnier LO, Yang XV, Griffin JH
- Issue date: 2007 Nov 9